The M48 USV begins production: Can Magnet Defense convert 40,000 nautical miles of sea trials into a Navy contract?
Venture Global (NYSE: VG) and Edison settle Calcasieu Pass arbitration, agree to expand LNG deliveries to Italy
Herald Investment Trust (LSE: HRI) board races to build cash war chest as Saba standoff stretches into spring
Read More 5 minute read Pharma Industry News Sanofi’s $9.5bn buyout of Blueprint Medicines signals high-stakes immunology expansion Sanofi’s $9.5B Blueprint Medicines acquisition strengthens its rare disease pipeline with Ayvakit and signals deeper investment in immunology. byPallavi MadhirajuJune 4, 2025